Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

AVITA Medical (RCEL) Profit After Tax (2018 - 2025)

AVITA Medical filings provide 8 years of Profit After Tax readings, the most recent being -$11.6 million for Q4 2025.

  • On a quarterly basis, Profit After Tax changed 0.28% to -$11.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$48.6 million, a 21.44% increase, with the full-year FY2025 number at -$48.6 million, up 21.44% from a year prior.
  • Profit After Tax hit -$11.6 million in Q4 2025 for AVITA Medical, up from -$13.2 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of -$4.7 million in Q2 2021 to a low of -$18.7 million in Q1 2024.
  • Median Profit After Tax over the past 5 years was -$9.7 million (2022), compared with a mean of -$10.2 million.
  • Biggest five-year swings in Profit After Tax: skyrocketed 63.47% in 2021 and later crashed 102.36% in 2024.
  • AVITA Medical's Profit After Tax stood at -$5.9 million in 2021, then increased by 10.0% to -$5.4 million in 2022, then crashed by 31.98% to -$7.1 million in 2023, then crashed by 64.03% to -$11.6 million in 2024, then decreased by 0.28% to -$11.6 million in 2025.
  • The last three reported values for Profit After Tax were -$11.6 million (Q4 2025), -$13.2 million (Q3 2025), and -$9.9 million (Q2 2025) per Business Quant data.